Nicholas Lorusso
Stock Analyst at TD Cowen
(3.86)
# 1,939
Out of 4,792 analysts
18
Total ratings
72.7%
Success rate
33.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nicholas Lorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IOVA Iovance Biotherapeutics | Rated: Buy | $10 | $8.14 | +22.85% | 1 | Aug 25, 2026 | |
| KROS Keros Therapeutics | Rated: Hold | n/a | $11.17 | - | 4 | Aug 21, 2026 | |
| IMTX Immatics | Reiterated: Buy | n/a | $8.75 | - | 5 | Aug 18, 2026 | |
| ARVN Arvinas | Reiterated: Hold | n/a | $8.71 | - | 1 | Aug 4, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Reiterated: Buy | $65 → $95 | $76.48 | +24.22% | 7 | Jul 28, 2026 |
Iovance Biotherapeutics
Aug 25, 2026
Rated: Buy
Price Target: $10
Current: $8.14
Upside: +22.85%
Keros Therapeutics
Aug 21, 2026
Rated: Hold
Price Target: n/a
Current: $11.17
Upside: -
Immatics
Aug 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.75
Upside: -
Arvinas
Aug 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.71
Upside: -
Kiniksa Pharmaceuticals International,
Jul 28, 2026
Reiterated: Buy
Price Target: $65 → $95
Current: $76.48
Upside: +24.22%